In angiotensin II (AngII) -induced apolipoprotein E-deficient (Apoe / -) mice, Liu et al. found that oral administration of Lut (100 mg / kg / day for 4 weeks) had a therapeutic effect on kidney injury, thus delaying the progression of kidney disease [18]. This evidence concerns the gene APOE and kidney disorder.